Pressmeddelande

BioStock: Biosergen's CEO - "this is a global health threat and it needs attention"

Cision Publicerad: 14 May 09:16

The Novo Nordisk Foundation, Wellcome, and the Bill & Melinda Gates Foundation have announced a USD 300 million initiative to support solutions for major global health threats, including infectious diseases. BioStock spoke with Tine Kold Olesen, CEO at Biosergen, a Swedish biotech developing drugs targeting life-threatening fungal infections, to get her take on this partnership and how it might impact small drug developers like Biosergen.

Read the article at biostock.se:

Biosergen's CEO: "this is a global health threat and it needs attention" - BioStock

This is a press release from BioStock - Connecting Innovation & Capital. https://www.biostock.se/en/

Nyheter om Biosergen

Läses av andra just nu

Innehåller annonslänkar. Investeringar innebär risk (se här)

Tips: 50% rabatt hos fondroboten Opti

Dags att komma igång med sparande? Fondroboten Opti erbjuder en populär spartjänst som är perfekt för regelbundet månadssparande. Just nu får nya kunder som använder Börskollens unika kampanjkod BORSKOLLEN50 automatiskt 50 % rabatt på Optis avgift i 3 månader!